These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4071 related articles for article (PubMed ID: 15743033)

  • 1. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
    Poyraz A; Akyürek N; Gönül II; Erdem O
    J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's esophagus, apoptosis and cell cycle regulation: correlation of p53 with Bax, Bcl-2 and p21 protein expression.
    Woodward TA; Klingler PD; Genko PV; Wolfe JT
    Anticancer Res; 2000; 20(4):2427-32. PubMed ID: 10953306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
    de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
    Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells.
    Kang KH; Kim WH; Choi KH
    Exp Cell Res; 1999 Dec; 253(2):403-12. PubMed ID: 10585263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings.
    Tchernev G; Orfanos CE
    J Cutan Pathol; 2007 Mar; 34(3):247-56. PubMed ID: 17302609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 plays a central role in UVA and UVB induced cell damage and apoptosis in melanoma cells.
    Zhang H
    Cancer Lett; 2006 Dec; 244(2):229-38. PubMed ID: 16504377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of p53, p21, bax and bcl-2 proteins in all-trans-retinoic acid treated primary and metastatic melanoma cells.
    Zhang H; Rosdahl I
    Int J Oncol; 2004 Aug; 25(2):303-8. PubMed ID: 15254726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
    Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
    Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apoptosis regulators in cutaneous malignant melanoma.
    Tang L; Tron VA; Reed JC; Mah KJ; Krajewska M; Li G; Zhou X; Ho VC; Trotter MJ
    Clin Cancer Res; 1998 Aug; 4(8):1865-71. PubMed ID: 9717813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
    Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
    J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Patereli A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2007 May; 56(5):815-24. PubMed ID: 17437889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
    Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
    J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
    Sabah M; Cummins R; Leader M; Kay E
    Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors.
    Mouriaux F; Maurage CA; Labalette P; Sablonnière B; Malecaze F; Darbon JM
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2837-43. PubMed ID: 10967035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
    Karjalainen JM; Eskelinen MJ; Kellokoski JK; Reinikainen M; Alhava EM; Kosma VM
    Br J Cancer; 1999 Feb; 79(5-6):895-902. PubMed ID: 10070887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
    Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
    Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 204.